Improve breathing with diaphragmatic stimulation
- Trial ID
- NCT04941326
- Official Title
- Investigation of the Effect of Spinal Mobilization and Respiration Techniques on Posture and Respiratory Function in Parkinson's Patients
- Goal
- Improve breathing with diaphragmatic stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Abant Izzet Baysal University
- Study Type
- INTERVENTIONAL
- Enrollment
- 63 participants
- Conditions
- Parkinson Disease, Camptocormia, Restrictive Lung Disease
- Interventions
- Diaphragmatic stimulation treatment with PNF techniques, Costal mobilization, Breathing exercises, Spinal mobilization, Sham mobilization
Plain-Language Summary
Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
Locations
- Abant Izzet Baysal University Faculty of Health Science, Bolu, Turkey (Türkiye)
- AIBU Physical Therapy and Rehabiltiation Department, Bolu, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Diaphragmatic stimulation treatment with PNF techniques. Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 4 months.